Chinese pharmaceutical company WuXi AppTec plans to acquire US-based contract research organisation (CRO) ResearchPoint Global (RPG).

RPG will become WuXi AppTec’s wholly owned subsidiary following the completion of the acquisition.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acquisition will help WuXi AppTec to strengthen its clinical research services worldwide.

“Chinese pharmaceutical company Cachet Pharmaceutical plans to acquire 51% stake in a Zhejiang-based biotechnology company for CNY43.8m ($6.65m).”

Chinese pharmaceutical company Cachet Pharmaceutical plans to acquire 51% stake in a Zhejiang-based biotechnology company for CNY43.8m ($6.65m).

Shenzhen Neptunus Bioengineering plans to acquire 10% stake in Shandong pharma company for CNY130m ($19.75m).

The Chinese pharmaceutical products manufacturer plans to pay the consideration in instalments through self-financing.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact